What can hospitals do to make sure all eligible patients get their tumors tested for biomarkers?
Approaching lung cancer from a multidisciplinary team approach is how we make sure that you have pathways in place so that patients don’t get missed. That there's communication between the surgeon, the oncologist, the pathologist: to obtain enough tissue, to make sure that tissue is appropriately handled, and then to communicate those results in a timely manner so the oncologist has that info when they see the patient and there aren't delays. It's also important that we educate each other.
For more information and to see the full recorded discussion, visit Lung.org/tumor-testing-videos.
Generously supported by AstraZeneca, Bristol-Myers Squibb, Foundation Medicine, Pfizer, and Merck & Co., Inc.
Page last updated: September 13, 2021